Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Vittecoq

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Joint Bone Spine|May 25, 2002
The sternocostoclavicular joint: normal and abnormal featuresXavier Le Loët, Olivier Vittecoq
Joint Bone Spine|July 12, 2015
Reply to the comment of Brinster et al. "Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists"Christopher Banse, Olivier Vittecoq, Hervé Lévesque
Joint Bone Spine|November 1, 2005
Rheumatoid arthritis in 2005: which patients should receive TNFalpha antagonists and when? A point of viewXavier Le Loët, Thierry Lequerré, Olivier Vittecoq
Joint Bone Spine|March 21, 2007
What is the role for interleukin-1 receptor antagonist in rheumatic disease?Thierry Lequerré, Olivier Vittecoq, Xavier le Loët
Joint Bone Spine|July 16, 2017
Effectiveness of vedolizumab for Crohn's disease with spondyloarthritis in fail with two TNF blocking agentsChristopher Banse, Laura Armengol-Debeir, Olivier Vittecoq
La Revue Du Praticien|May 11, 2002
[Synovial diseases of the hip]Xavier Le Loët, Sophie Pouplin, Olivier Vittecoq
Presse Medicale (Paris, France : 1983)|March 31, 2009
[Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis]Karine Lanfant-Weybel, Thierry Lequerré, Olivier Vittecoq
Joint Bone Spine|July 26, 2005
Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally"Thierry Lequerré, Olivier Vittecoq, Xavier Le Loët
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 11, 2023
Lupus With Erosive Arthritis: A Singular Joint Phenotype of Lupus or Rhupus?Olivier Vittecoq, Pauline Brevet, Nans Lebel, et al.
RMD Open|October 10, 2024
Immune reactivity directed against the carbamylated fibrinogen α chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritisPauline Brevet, Olivier Boyer, Olivier Vittecoq, et al.
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Joint Bone Spine|May 25, 2002
The sternocostoclavicular joint: normal and abnormal featuresXavier Le Loët, Olivier Vittecoq
Joint Bone Spine|July 12, 2015
Reply to the comment of Brinster et al. "Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists"Christopher Banse, Olivier Vittecoq, Hervé Lévesque
Joint Bone Spine|November 1, 2005
Rheumatoid arthritis in 2005: which patients should receive TNFalpha antagonists and when? A point of viewXavier Le Loët, Thierry Lequerré, Olivier Vittecoq
Joint Bone Spine|March 21, 2007
What is the role for interleukin-1 receptor antagonist in rheumatic disease?Thierry Lequerré, Olivier Vittecoq, Xavier le Loët
Joint Bone Spine|July 16, 2017
Effectiveness of vedolizumab for Crohn's disease with spondyloarthritis in fail with two TNF blocking agentsChristopher Banse, Laura Armengol-Debeir, Olivier Vittecoq
La Revue Du Praticien|May 11, 2002
[Synovial diseases of the hip]Xavier Le Loët, Sophie Pouplin, Olivier Vittecoq
Presse Medicale (Paris, France : 1983)|March 31, 2009
[Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis]Karine Lanfant-Weybel, Thierry Lequerré, Olivier Vittecoq
Joint Bone Spine|July 26, 2005
Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally"Thierry Lequerré, Olivier Vittecoq, Xavier Le Loët
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 11, 2023
Lupus With Erosive Arthritis: A Singular Joint Phenotype of Lupus or Rhupus?Olivier Vittecoq, Pauline Brevet, Nans Lebel, et al.
RMD Open|October 10, 2024
Immune reactivity directed against the carbamylated fibrinogen α chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritisPauline Brevet, Olivier Boyer, Olivier Vittecoq, et al.
Pageof 15